全文获取类型
收费全文 | 68061篇 |
免费 | 4450篇 |
国内免费 | 3114篇 |
专业分类
耳鼻咽喉 | 795篇 |
儿科学 | 840篇 |
妇产科学 | 730篇 |
基础医学 | 5719篇 |
口腔科学 | 1047篇 |
临床医学 | 6818篇 |
内科学 | 9458篇 |
皮肤病学 | 902篇 |
神经病学 | 2185篇 |
特种医学 | 1821篇 |
外国民族医学 | 6篇 |
外科学 | 7768篇 |
综合类 | 10796篇 |
现状与发展 | 3篇 |
预防医学 | 5600篇 |
眼科学 | 629篇 |
药学 | 9495篇 |
19篇 | |
中国医学 | 3596篇 |
肿瘤学 | 7398篇 |
出版年
2024年 | 97篇 |
2023年 | 659篇 |
2022年 | 1567篇 |
2021年 | 2085篇 |
2020年 | 1586篇 |
2019年 | 3919篇 |
2018年 | 3496篇 |
2017年 | 2223篇 |
2016年 | 1803篇 |
2015年 | 2216篇 |
2014年 | 4776篇 |
2013年 | 4186篇 |
2012年 | 3882篇 |
2011年 | 3972篇 |
2010年 | 3618篇 |
2009年 | 4090篇 |
2008年 | 3276篇 |
2007年 | 4178篇 |
2006年 | 3746篇 |
2005年 | 3069篇 |
2004年 | 1752篇 |
2003年 | 1754篇 |
2002年 | 1435篇 |
2001年 | 1272篇 |
2000年 | 1140篇 |
1999年 | 904篇 |
1998年 | 821篇 |
1997年 | 741篇 |
1996年 | 714篇 |
1995年 | 602篇 |
1994年 | 545篇 |
1993年 | 397篇 |
1992年 | 363篇 |
1991年 | 343篇 |
1990年 | 268篇 |
1989年 | 259篇 |
1988年 | 194篇 |
1987年 | 228篇 |
1986年 | 203篇 |
1985年 | 514篇 |
1984年 | 528篇 |
1983年 | 367篇 |
1982年 | 368篇 |
1981年 | 287篇 |
1980年 | 311篇 |
1979年 | 227篇 |
1978年 | 135篇 |
1977年 | 124篇 |
1976年 | 112篇 |
1974年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
36.
37.
《Drug metabolism and pharmacokinetics》2019,34(1):87-94
The purpose of this study was to elucidate the involvement of Mate1 in the tubular secretion of trimethoprim and saturation of Mate1-mediated efflux to address the mechanisms underlying the pharmacokinetic drug interactions with trimethoprim. Trimethoprim is a more potent inhibitor of MATE2-K than MATE1 with Ki values (μM) of 0.030–0.28 and 2.4–5.9, respectively. Trimethoprim is a substrate of human MATE1 and MATE2-K with Km values of 2.3 ± 0.9 and 0.018 ± 0.004 μM, and mouse Mate1, but not human OCT2, mouse Oct1 and Oct2. Pyrimethamine significantly reduced the renal clearance (CLR) of trimethoprim (mL/min/kg) from 40.0 ± 5.1 to 20.1 ± 3.7 (p < 0.05). Trimethoprim was given to mice at three infusion rates (150, 500, and 1500 nmol/min/kg). Together with an increase in the plasma concentrations of trimethoprim, the CLR (mL/min/kg) of trimethoprim decreased to 25.9 ± 3.2, 13.5 ± 5.7, and 8.92 ± 1.50 at the respective rates. Trimethoprim decreased the CLR of rhodamine 123 in an infusion rate-dependent manner: 11.5 ± 1.3 (control), 5.17 ± 1.55, 1.31 ± 0.50, and 0.532 ± 0.180. These results suggest that Mate1 mediates the tubular secretion of trimethoprim, and at therapeutic doses, MATEs-mediated efflux can be saturated, and thereby, cause drug interactions with other MATE substrates. 相似文献
38.
Jennifer Wang Jonathan G. Stine Scott L. Cornella Curtis K. Argo Steven M. Cohn 《临床与转化肝病杂志(英文版)》2015,3(4):254-259
Background and Aims: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. Methods: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014. Patients were categorized into cirrhosis and noncirrhosis groups, and those with an additional GI bleeding source were excluded. Univariate comparisons and multivariable models were constructed using logistic regression. Results: In total, 110 patients diagnosed with GAVE on esophagogastroduodenoscopy (EGD) were included in our analysis; 84 patients had cirrhosis (76.4%) and 26 (23.6%) did not. Active GI bleeding was more prevalent in patients without cirrhosis (63.4% vs. 32.1%, p=0.003) despite similar indications for EGD, and endoscopic treatment with argon plasma coagulation (APC) was required more often in this group, approaching statistical significance (27% vs. 10.7%, p=0.056). There was no difference in bleeding severity, as evidenced by similar re-bleeding rates, surgery, or death attributed to uncontrolled bleeding. The strongest independent risk factor for GI bleeding was the absence of cirrhosis (odds ratio (OR): 5.151 (95% confidence interval (CI): 1.08-24.48, p=0.039). Conclusions: Patients with GAVE in the absence of cirrhosis are at higher risk for active GI bleeding and require more frequent endoscopic treatment than similar patients with cirrhosis. It may be worthwhile to treat GAVE in this population even in the absence of active bleeding. 相似文献
39.
Carlos Robles-Medranda Manuel Valero Miguel Puga-Tejada Roberto Oleas Jorge Baquerizo-Burgos Miguel Soria-Alc var Haydee Alvarado-Escobar Hannah Pitanga-Lukashok 《World journal of gastrointestinal endoscopy》2020,12(1):23-32
BACKGROUND Accurate detection of gastric infection by Helicobacter pylori(H.pylori) and premalignant lesions are important for effective provision of treatment,preventing the development of gastric neoplasia.Optical enhancement systems with optical magnification improved the identification of mucosal superficial and vascular patterns in patients with dyspepsia.AIM To evaluate an optical enhancement system with high-definition magnification,for diagnosis of normal gastric mucosa,H.pylori-associated gastritis,and gastric atrophy.METHODS A cross-sectional,nonrandomized study from November 2015 to April 2016 performed in a single-tertiary academic center from Ecuador.Seventy-two consecutive patients with functional dyspepsia according to the Rome III criteria,were tested for H.pylori using a stool antigen test and were assigned to an Hp+group or an Hp-control group.Esophagogastroduodenoscopy with highdefinition optical magnification and digital chromoendoscopy was performed,and patients were classified into 4 groups,in accordance to the microvasculararchitecture pattern of the mucosa.Interobserver and intraobserver agreement among operators were calculated.RESULTS Of the 72 participants,35 were Hp+ and 37 were Hp-.Among 10 patients with normal mucosal histology in biopsy samples,90% had a Type I pattern of microvascular architecture by endoscopy.Among participants with type IIa and type IIb patterns,significantly more were Hp+ than Hp-(32 vs 8),and most(31 out of 40) had histological diagnoses of chronic active gastritis.Two of the three participants with a histological diagnosis of atrophy had a type III microvascular pattern.The type I pattern predicted normal mucosa,type IIa–IIb predicted H.pylori infection,and type III predicted atrophy with sensitivities of 90.0%,91.4%,and 66.7%,respectively.The intraobserver and interobserver agreements had kappa values of 0.91 and 0.89,respectively.CONCLUSION High-definition optical magnification with digital chromoendoscopy is useful for diagnosis of normal gastric mucosa and H.pylori-associated gastritis with high accuracy,but further studies are needed to determine whether endoscopic diagnosis of gastric atrophy is feasible. 相似文献